A dynamic DNA tetrahedron framework for active targeting

Taoran Tian, Tao Zhang, Sirong Shi, Yang Gao, Xiaoxiao Cai, Yunfeng Lin

Published: 2023-01-19 DOI: 10.1038/s41596-022-00791-7

biocompatibility

drug delivery

DNA tetrahedron

active targeting

stimuli-responsive

AI 解读

Generation of mouse–human chimeric embryos

Genome-wide quantification of transcription factor binding at single-DNA-molecule resolution using methyl-transferase footprinting

Generation of CRISPR–Cas9-mediated genetic knockout human intestinal tissue–derived enteroid lines by lentivirus transduction and single-cell cloning

A puromycin-dependent activity-based sensing probe for histochemical staining of hydrogen peroxide in cells and animal tissues

Decoding personal biotic and abiotic airborne exposome

A clinically relevant model of focal embolic cerebral ischemia by thrombus and thrombolysis in rhesus monkeys

Bioengineering human intestinal mucosal grafts using patient-derived organoids, fibroblasts and scaffolds

Biomimetic tail-to-head terpene cyclizations using the resorcin[4]arene capsule catalyst

Neuroscience robotics for controlled induction and real-time assessment of hallucinations

Scanorama: integrating large and diverse single-cell transcriptomic datasets

Single-cell RNA sequencing (scRNA-seq)（单细胞RNA测序）

Data integration（数据集成）

Heterogeneity（异质性）

查看全部

Sections

Figures

References

An active targeting strategy-enabled DNA tetrahedron delivery vehicle could facilitate stable drug encapsulation and stimuli-responsive on-demand release, building a universal platform for different drug delivery requirements. Owing to the excellent bioco
Introduction
Materials
Procedure
Troubleshooting
Timing
Anticipated results
- Reporting summary
- References
References
ACKNOWLEDGMENTS

Seeman, N. C. Nucleic acid nanostructures and topology. Angew. Chem. Int. Ed. Engl. 37, 3220–3238 (1998).
Zhu, J. et al. antiepilepticus effects of tetrahedral framework nucleic acid via inhibition of gliosis-induced downregulation of glutamine synthetase and increased AMPAR internalization in the postsynaptic membrane. Nano Lett. 22, 2381–2390 (2022).
Wang, Y. et al. Tetrahedral framework nucleic acids can alleviate taurocholate-induced severe acute pancreatitis and its subsequent multiorgan injury in mice. Nano Lett. 22, 1759–1768 (2022).
Yan, J. et al. Redox-responsive polyethyleneimine/tetrahedron DNA/doxorubicin nanocomplexes for deep cell/tissue penetration to overcome multidrug resistance. J. Control. Release 329, 36–49 (2021).
Zhang, T. et al. Design, fabrication and applications of tetrahedral DNA nanostructure-based multifunctional complexes in drug delivery and biomedical treatment. Nat. Protoc. 15, 2728–2757 (2020).
Zhang, Y. et al. Inhibiting methicillin-resistant Staphylococcus aureus by tetrahedral DNA nanostructure-enabled antisense peptide nucleic acid delivery. Nano Lett. 18, 5652–5659 (2018).
Ma, W. et al. An intelligent DNA nanorobot with in vitro enhanced protein lysosomal degradation of HER2. Nano Lett. 19, 4505–4517 (2019).
Li, S. et al. Bioswitchable delivery of microRNA by framework nucleic acids: application to bone regeneration. Small 17, e2104359 (2021).
Zhang, X. et al. Tetrahedral-framework nucleic acids carry small interfering RNA to downregulate toll-like receptor 2 gene expression for the treatment of sepsis. ACS Appl. Mater. Interfaces 14, 6442–6452 (2022).
Li, J. et al. Modulation of the crosstalk between Schwann cells and macrophages for nerve regeneration: a therapeutic strategy based on a multifunctional tetrahedral framework nucleic acids system. Adv. Mater. 28, 2202513 (2022).
Ma, W. et al. Biomimetic nanoerythrosome-coated aptamer–DNA tetrahedron/maytansine conjugates: pH-responsive and targeted cytotoxicity for HER2-positive breast cancer. Adv. Mater. 34, 2109609 (2022).
Fu, W. et al. Therapeutic siCCR2 loaded by tetrahedral framework DNA nanorobotics in therapy for intracranial hemorrhage. Adv. Funct. Mater. 31, 2101435 (2021).
Liu, Y. et al. Tetrahedral framework nucleic acids deliver antimicrobial peptides with improved effects and less susceptibility to bacterial degradation. Nano Lett. 20, 3602–3610 (2020).
Zhang, M. et al. Anti-inflammatory activity of curcumin-loaded tetrahedral framework nucleic acids on acute gouty arthritis. Bioact. Mater. 8, 368–380 (2022).
Zhang, T., Tian, T. & Lin, Y. Functionalizing framework nucleic-acid-based nanostructures for biomedical application. Adv. Mater. 17, 2107820 (2022).
He, Z. et al. Gold nanorods/tetrahedral DNA composites for chemo-photothermal therapy. Regen. Biomater. 9, rbac032 (2022).
Tian, T. et al. A framework nucleic acid based robotic nanobee for active targeting therapy. Adv. Funct. Mater. 31, 2007342 (2020).
Gao, Y. et al. A lysosome-activated tetrahedral nanobox for encapsulated siRNA delivery. Adv. Mater. 5, e2201731 (2022).
Xie, X. et al. Overcoming drug-resistant lung cancer by paclitaxel loaded tetrahedral DNA nanostructures. Nanoscale 10, 5457–5465 (2018).
Shi, S. et al. Effects of tetrahedral framework nucleic acid/wogonin complexes on osteoarthritis. Bone Res. 8, 6 (2020).
Madhanagopal, B. R., Zhang, S., Demirel, E., Wady, H. & Chandrasekaran, A. R. DNA nanocarriers: programmed to deliver. Trends Biochem. Sci. 43, 997–1013 (2018).
Li, Y. et al. Tetrahedral framework nucleic acid-based delivery of resveratrol alleviates insulin resistance: from innate to adaptive immunity. Nanomicro Lett. 13, 86 (2021).
Qin, X. et al. Tetrahedral framework nucleic acids-based delivery of microRNA-155 inhibits choroidal neovascularization by regulating the polarization of macrophages. Bioact. Mater. 14, 134–144 (2022).
Li, J. et al. The neuroprotective effect of microRNA-22-3p modified tetrahedral framework nucleic acids on damaged retinal neurons via TrkB/BDNF signaling pathway. Adv. Funct. Mater. 31, 2104141 (2021).
Lee, H. et al. Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat. Nanotechnol. 7, 389–393 (2012).
Liang, L. et al. Single-particle tracking and modulation of cell entry pathways of a tetrahedral DNA nanostructure in live cells. Angew. Chem. Int. Ed. Engl. 53, 7745–7750 (2014).
Wiraja, C. et al. Framework nucleic acids as programmable carrier for transdermal drug delivery. Nat. Commun. 10, 1147 (2019).
Zhou, M. et al. A DNA nanostructure-based neuroprotectant against neuronal apoptosis via inhibiting Toll-like receptor 2 signaling pathway in acute ischemic stroke. ACS Nano 16, 1456–1470 (2022).
Li, Q. et al. Aptamer-modified tetrahedral DNA nanostructure for tumor-targeted drug delivery. ACS Appl. Mater. Interfaces 9, 36695–36701 (2017).
Cui, W. et al. Treating LRRK2-related Parkinson’s disease by inhibiting the mTOR signaling pathway to restore autophagy. Adv. Funct. Mater. 31, 2105152 (2021).
Sun, Y. et al. Erythromycin loaded by tetrahedral framework nucleic acids are more antimicrobial sensitive against Escherichia coli (E. coli). Bioact. Mater. 6, 2281–2290 (2021).
Gao, P. et al. Antitumor agents based on metal–organic frameworks. Angew. Chem. Int. Ed. Engl. 60, 16763–16776 (2021).
Wu, M. X. & Yang, Y. W. Metal–organic framework (MOF)-based drug/cargo delivery and cancer therapy. Adv. Mater. 29, 1606134 (2017).
Li, S. et al. A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo. Nat. Biotechnol. 36, 258–264 (2018).
Bhatia, D., Surana, S., Chakraborty, S., Koushika, S. P. & Krishnan, Y. A synthetic icosahedral DNA-based host–cargo complex for functional in vivo imaging. Nat. Commun. 2, 339 (2011).
Ma, W. et al. Biomimetic nanoerythrosome-coated aptamer-DNA tetrahedron/maytansine conjugates: pH-responsive and targeted cytotoxicity for HER2-positive breast cancer. Adv. Mater. 22, e2109609 (2022).
Banerjee, A. et al. Controlled release of encapsulated cargo from a DNA icosahedron using a chemical trigger. Angew. Chem. Int. Ed. Engl. 52, 6854–6857 (2013).
Andersen, E. S. et al. Self-assembly of a nanoscale DNA box with a controllable lid. Nature 459, 73–U75 (2009).
Ranjbar, R. & Hafezi-Moghadam, M. S. Design and construction of a DNA origami drug delivery system based on MPT64 antibody aptamer for tuberculosis treatment. Electron. Physician 8, 1857–1864 (2016).
Tan, X. et al. Blurring the role of oligonucleotides: spherical nucleic acids as a drug delivery vehicle. J. Am. Chem. Soc. 138, 10834–10837 (2016).
Rajwar, A. et al. Geometry of a DNA nanostructure influences its endocytosis: Cellular study on 2D, 3D, and in vivo systems. ACS Nano 16, 10496–10508 (2022).
Zhang, B. et al. Facilitating in-situ tumor imaging with a tetrahedral DNA framework-enhanced hybridization chain reaction probe. Adv. Funct. Mater. 32, 2109728 (2022).
Zhang, T., Tian, T. & Lin, Y. Functionalizing framework nucleic-acid-based nanostructures for biomedical application. Adv. Mater. 34, 2107820 (2022).
Shi, S. et al. Biological effect of differently sized tetrahedral framework nucleic acids: Endocytosis, proliferation, migration, and biodistribution. ACS Appl. Mater. Interfaces 13, 57067–57074 (2021).
Tian, T., Li, Y. & Lin, Y. Prospects and challenges of dynamic DNA nanostructures in biomedical applications. Bone Res. 10, 40 (2022).
Sefah, K., Shangguan, D., Xiong, X., O’Donoghue, M. B. & Tan, W. Development of DNA aptamers using Cell-SELEX. Nat. Protoc. 5, 1169–1185 (2010).
Xing, H., Wong, N. Y., Xiang, Y. & Lu, Y. DNA aptamer functionalized nanomaterials for intracellular analysis, cancer cell imaging and drug delivery. Curr. Opin. Chem. Biol. 16, 429–435 (2012).
Hirao, I., Kimoto, M. & Lee, K. H. DNA aptamer generation by ExSELEX using genetic alphabet expansion with a mini-hairpin DNA stabilization method. Biochimie 145, 15–21 (2018).
Cansiz, S. et al. DNA aptamer based nanodrugs: molecular engineering for efficiency. Chem. Asian J. 10, 2084–2094 (2015).
Lin, M. et al. Electrochemical detection of nucleic acids, proteins, small molecules and cells using a DNA-nanostructure-based universal biosensing platform. Nat. Protoc. 11, 1244–1263 (2016).
Skolakova, P. et al. Systematic investigation of sequence requirements for DNA i-motif formation. Nucleic Acids Res. 47, 2177–2189 (2019).
Abou Assi, H., Garavis, M., Gonzalez, C. & Damha, M. J. i-Motif DNA: structural features and significance to cell biology. Nucleic Acids Res. 46, 8038–8056 (2018).
Guo, K. et al. Formation of pseudosymmetrical G-quadruplex and i-motif structures in the proximal promoter region of the RET oncogene. J. Am. Chem. Soc. 129, 10220–10228 (2007).
Chu, B., Zhang, D. & Paukstelis, P. J. A DNA G-quadruplex/i-motif hybrid. Nucleic Acids Res. 47, 11921–11930 (2019).
Shi, S. et al. Targeted and effective glioblastoma therapy via aptamer-modified tetrahedral framework nucleic acid-paclitaxel nanoconjugates that can pass the blood brain barrier. Nanomed 21, 102061 (2019).
Tucker, W. O., Shum, K. T. & Tanner, J. A. G-quadruplex DNA aptamers and their ligands: structure, function and application. Curr. Pharm. Des. 18, 2014–2026 (2012).
Mondragón-Sánchez, J. A., Santamaria, R. & Garduño-Juárez, R. Docking on the DNA G-quadruplex: a molecular electrostatic potential study. Biopolymers 95, 641–650 (2011).
Williams, B. A. et al. Creating protein affinity reagents by combining peptide ligands on synthetic DNA scaffolds. J. Am. Chem. Soc. 131, 17233–17241 (2009).
Liu, H. et al. Kinetics of RNA and RNA:DNA hybrid strand displacement. ACS Synth. Biol. 10, 3066–3073 (2021).
Erben, C. M., Goodman, R. P. & Turberfield, A. J. Single-molecule protein encapsulation in a rigid DNA cage. Angew. Chem. Int. Ed. Engl. 45, 7414–7417 (2006).
Ke, Y., Bellot, G., Voigt, N. V., Fradkov, E. & Shih, W. M. Two design strategies for enhancement of multilayer-DNA-origami folding: underwinding for specific intercalator rescue and staple-break positioning. Chem. Sci. 3, 2587–2597 (2012).
Li, S. et al. A tetrahedral framework DNA-based bioswitchable miRNA inhibitor delivery system: application to skin anti-aging. Adv. Mater. 28, e2204287 (2022).
Xing, S. et al. Constructing higher-order DNA nanoarchitectures with highly purified DNA nanocages. ACS Appl. Mater. Interfaces 7, 13174–13179 (2015).

A dynamic DNA tetrahedron framework for active targeting

Supplementary information

Reporting Summary

推荐阅读